The suspension comes weeks after UnitedHealth cut its full-year profit forecast while reported first-quarter results below expectations. The performance and reduced forecast led to a 22% share decline ...

The company never told investors how it planned to shift its strategy following public backlash and increased government ...

Q1 2025 Earnings Call Transcript May 6, 2025 Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $-0.03, ...

UnitedHealth slashes 2025 profit forecast to $26–$26.50/share, far below analyst expectations of $29.73. Persistent Medicare Advantage costs continue to pressure margins and drive forecast ...

Buffett, whose Berkshire Hathaway will host its annual meeting this Saturday, has held his tongue on what Trump's tariffs mean for economies and markets. "Black in Business," one program in the effort ...

Major indices were in the green early on Thursday as investors cheered quarterly earnings beats from tech giants Meta ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists ...

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers ...

Molina Healthcare beat Wall Street estimates for first-quarter earnings on Wednesday, driven by an increase in premiums from its government-backed Medicaid insurance plans for people with low income.